Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Eguiluz-Gracia

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Allergy and Asthma Reports|May 21, 2020
Allergen Immunotherapy for Local Respiratory AllergyI Eguiluz-Gracia, A Ariza, A Testera-Montes, et al.
Allergy|August 24, 2017
Local allergic rhinitis is an independent rhinitis phenotype: The results of a 10-year follow-up studyC Rondon, P Campo, I Eguiluz-Gracia, et al.
Rhinology|March 27, 2026
Reconsidering biologic treatment recommendations for CRSwNP without asthma in EUFOREA guidelinesJ Oppenheimer, G W Canonica, P Chanez, et al.
Rhinology|December 11, 2024
Global airway disease: mepolizumab simultaneously improves outcomes in severe CRSwNP and asthmaJ Mullol, V Backer, J Constantinidis, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 15, 2018
Local allergic rhinitis: Implications for managementP Campo, I Eguiluz-Gracia, G Bogas, et al.
Allergy|April 1, 2023
Organ-specific allergen challenges in airway allergy: Current utilities and future directionsJ L Fauquert, C Alba-Linero, A Gherasim, et al.
Allergy|September 30, 2017
The roadmap for allergology in Europe: The subspecialty of allergology as "stop-over" on the way to a full specialty. An EAACI position statementR Gerth van Wijk, I Eguiluz-Gracia, J Gayraud, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 12, 2024
Biomarkers predicting the controller dose of omalizumab in patients with chronic spontaneous urticariaL Zubiaga-Fernandez, A Testera-Montes, C Rondon, et al.
Allergy|February 7, 2026
Update on Non-Biological and RNA-Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small MoleculesF Roth-Walter, I M Adcock, C Benito-Villalvilla, et al.
Allergy|December 18, 2023
Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for ImmunopharmacologyF Roth-Walter, I M Adcock, C Benito-Villalvilla, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Allergy and Asthma Reports|May 21, 2020
Allergen Immunotherapy for Local Respiratory AllergyI Eguiluz-Gracia, A Ariza, A Testera-Montes, et al.
Allergy|August 24, 2017
Local allergic rhinitis is an independent rhinitis phenotype: The results of a 10-year follow-up studyC Rondon, P Campo, I Eguiluz-Gracia, et al.
Rhinology|March 27, 2026
Reconsidering biologic treatment recommendations for CRSwNP without asthma in EUFOREA guidelinesJ Oppenheimer, G W Canonica, P Chanez, et al.
Rhinology|December 11, 2024
Global airway disease: mepolizumab simultaneously improves outcomes in severe CRSwNP and asthmaJ Mullol, V Backer, J Constantinidis, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 15, 2018
Local allergic rhinitis: Implications for managementP Campo, I Eguiluz-Gracia, G Bogas, et al.
Allergy|April 1, 2023
Organ-specific allergen challenges in airway allergy: Current utilities and future directionsJ L Fauquert, C Alba-Linero, A Gherasim, et al.
Allergy|September 30, 2017
The roadmap for allergology in Europe: The subspecialty of allergology as "stop-over" on the way to a full specialty. An EAACI position statementR Gerth van Wijk, I Eguiluz-Gracia, J Gayraud, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 12, 2024
Biomarkers predicting the controller dose of omalizumab in patients with chronic spontaneous urticariaL Zubiaga-Fernandez, A Testera-Montes, C Rondon, et al.
Allergy|February 7, 2026
Update on Non-Biological and RNA-Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small MoleculesF Roth-Walter, I M Adcock, C Benito-Villalvilla, et al.
Allergy|December 18, 2023
Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for ImmunopharmacologyF Roth-Walter, I M Adcock, C Benito-Villalvilla, et al.
Pageof 2